Come up with a name for your new list and we'll add to it:
Vyriad raised a round of funding on April 13, 2017. Investors include
Mayo Clinic Business Accelerator.
Vyriad is a clinical-stage biotechnology company developing novel oncolytic virus therapies for the treatment of cancers that have significant unmet need. Vyriad's oncolytic immunovirotherapy products…